These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1178 related articles for article (PubMed ID: 16890276)
1. Indications for primary and secondary exenterations in patients with cervical cancer. Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276 [TBL] [Abstract][Full Text] [Related]
2. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Schmidt AM; Imesch P; Fink D; Egger H Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639 [TBL] [Abstract][Full Text] [Related]
3. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947 [TBL] [Abstract][Full Text] [Related]
4. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259 [TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945 [TBL] [Abstract][Full Text] [Related]
6. Outcome of total pelvic exenteration for locally recurrent rectal cancer. Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064 [TBL] [Abstract][Full Text] [Related]
7. Primary pelvic exenteration in cervical cancer patients. Ungar L; Palfalvi L; Novak Z Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Houvenaeghel G; Lelievre L; Gonzague-Casabianca L; Buttarelli M; Moutardier V; Goncalves A; Resbeut M Gynecol Oncol; 2006 Feb; 100(2):338-43. PubMed ID: 16213008 [TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for adenocarcinoma of the uterine cervix. Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894 [TBL] [Abstract][Full Text] [Related]
14. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases]. Janser JC; Rodier JF; Rodier D; Vergnes Y Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894 [TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for primary and recurrent gynaecological malignancies. de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559 [TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration. Has it a role in 1987? A six year experience. Shepherd JH Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684 [TBL] [Abstract][Full Text] [Related]
17. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy. Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428 [TBL] [Abstract][Full Text] [Related]
19. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival. Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775 [TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Morris M; Alvarez RD; Kinney WK; Wilson TO Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]